Palo Alto, California, United States The main office of represented VC is situated in the Palo Alto. The venture was found in North America in United States.
We also calculated 8 valuable employees in our database.
For fund there is a match between the location of its establishment and the land of its numerous investments - United States. Besides, a startup needs to be aged 4-5 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight TRIA Beauty, Beamreach, Accelergy. The fund has exact preference in a number of founders of portfolio startups. Among the most popular fund investment industries, there are Therapeutics, Manufacturing.
The usual cause for the fund is to invest in rounds with 4-5 partakers. Despite the Technology Partners, startups are often financed by U.S. Venture Partners (USVP), Morgenthaler Ventures, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are Morgenthaler Ventures, Kleiner Perkins, Versant Ventures. In the next rounds fund is usually obtained by Vivo Capital, Kleiner Perkins, DeNovo Ventures.
The top activity for fund was in 2012. The top amount of exits for fund were in 2013. This Technology Partners works on 2 percentage points less the average amount of lead investments comparing to the other organizations. Deals in the range of 10 - 50 millions dollars are the general things for fund. The real fund results show that this VC is 2 percentage points less often commits exit comparing to other companies. The fund is constantly included in 2-6 deals per year. The typical startup value when the investment from Technology Partners is 10-50 millions dollars.
Related Funds
Funds with similar focus
| Fund Name | Location |
| ALPS Information Technology Fund | Auburn Hills, Michigan, United States |
| Buffalo Ventures | - |
| C5 Accelerate | England, London, United Kingdom |
| Canrock Ventures | Hicksville, New York, United States |
| Chuangzhi Capital | - |
| Dalian Juntai | China, Dalian, Zhejiang |
| Ensis Growth Fund | Canada, Manitoba, Winnipeg |
| Huoshanshi Capital | China, Shanghai |
| iCarbonX | China, Guangdong, Shenzhen |
| Impact Venture Partners | New York, New York, United States |
| Leoch Battery | China, Guangdong, Shenzhen |
| Magic Leap | Florida, Plantation, United States |
| Rykadan Capital | - |
| Shenzhen Renyuan Guoying Touzi Guanli Qiye (Youxian Hehuo) | China, Guangdong, Shenzhen |
| UCSF Foundation Investment Company | California, San Francisco, United States |
| University of Southampton | England, Southampton, United Kingdom |
| WNT Ventures | Gisborne, New Zealand, Tauranga |
| Zephyr Peacock India | Bengaluru, India, Karnataka |
| zipdragon ventures | California, San Francisco, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
ForSight VISION5 | $15M | 16 Apr 2014 | California, United States | ||
Transcend Medical | $29M | 02 Apr 2014 | California, United States | ||
Elcelyx Therapeutics | $24M | 20 Feb 2014 | San Diego, California, United States | ||
| $54M | 22 Aug 2013 | Milpitas, California, United States | |||
ForSight Labs | $9M | 17 Jun 2013 | California, United States | ||
Scioderm | $16M | 26 Apr 2013 | Durham, North Carolina, United States | ||
Elcelyx Therapeutics | $4M | 13 Aug 2012 | San Diego, California, United States | ||
Beamreach | $10M | 01 Jul 2012 | Milpitas, California, United States | ||
Beamreach | $25M | 01 Apr 2012 | Milpitas, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
ForSight VISION5 | $15M | 16 Apr 2014 | California, United States | ||
Transcend Medical | $29M | 02 Apr 2014 | California, United States | ||
Elcelyx Therapeutics | $24M | 20 Feb 2014 | San Diego, California, United States | ||
| $54M | 22 Aug 2013 | Milpitas, California, United States | |||
ForSight Labs | $9M | 17 Jun 2013 | California, United States | ||
Scioderm | $16M | 26 Apr 2013 | Durham, North Carolina, United States | ||
Elcelyx Therapeutics | $4M | 13 Aug 2012 | San Diego, California, United States | ||
Beamreach | $10M | 01 Jul 2012 | Milpitas, California, United States | ||
Beamreach | $25M | 01 Apr 2012 | Milpitas, California, United States |
